Chemotherapy

Chemotherapy, in its most general sense, is the treatment of disease by chemicals especially by killing micro-organisms or cancerous cells. In popular usage, it refers to antineoplastic drugs used to treat cancer or the combination of these drugs into a cytotoxic standardized treatment regimen.
What is Chemotherapy?

Chemotherapy literally refers to the treatment of certain diseases using specific chemicals that are destructive to malignant cells or to the causative agent of a disease such as a bacteria or virus. Therefore, the treatment can be broadly divided into two categories - cancer chemotherapy and antimicrobial chemotherapy.

Read More

Overview

Feature Articles

Latest Chemotherapy News and Research

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

Targeted therapy for non-small cell lung cancer provides benefit to patients after surgery

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

Single dose of anti-Müllerian hormone gene therapy can induce long-term contraception in domestic cats

Single dose of anti-Müllerian hormone gene therapy can induce long-term contraception in domestic cats

New type of wound dressing could enhance the healing process for burn patients

New type of wound dressing could enhance the healing process for burn patients

HER2-targeted antibody drug conjugate shows encouraging responses, long-lasting clinical benefit in several tumor types

HER2-targeted antibody drug conjugate shows encouraging responses, long-lasting clinical benefit in several tumor types

Phase III ZUMA-7 trial: Patients with high-risk large B-cell lymphoma lived longer with axi-cel

Phase III ZUMA-7 trial: Patients with high-risk large B-cell lymphoma lived longer with axi-cel

Clinical trials demonstrate positive results from targeted therapy for patients with multiple tumor types with FGFR alterations

Clinical trials demonstrate positive results from targeted therapy for patients with multiple tumor types with FGFR alterations

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

Study suggests possible new treatment option for people with slow-growing but deadly brain tumor

Study suggests possible new treatment option for people with slow-growing but deadly brain tumor

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

Stopping treatment at two years does not seem to compromise overall survival in patients with advanced lung cancer

Stopping treatment at two years does not seem to compromise overall survival in patients with advanced lung cancer

Study shows efficacy and safety of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

Study shows efficacy and safety of novel FolRα-targeting antibody drug conjugate in recurrent epithelial ovarian cancer

NCI launches new initiative to test new drug combinations that target specific tumor alterations

NCI launches new initiative to test new drug combinations that target specific tumor alterations

New data guides treatment choices for patients with r/r lymphoma during pregnancy

New data guides treatment choices for patients with r/r lymphoma during pregnancy

Study sheds light on metabolic enzymes and processes essential for DNA damage repair

Study sheds light on metabolic enzymes and processes essential for DNA damage repair

Breast cancer patients experience more severe CIPN symptoms with paclitaxel

Breast cancer patients experience more severe CIPN symptoms with paclitaxel

Novel treatment targets against natural killer/T-cell lymphoma identified

Novel treatment targets against natural killer/T-cell lymphoma identified

New understanding of chemotherapeutic resistance in recurring ovarian cancer

New understanding of chemotherapeutic resistance in recurring ovarian cancer

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Telephone-based weight loss program can help patients with breast cancer to reduce their weight

Telephone-based weight loss program can help patients with breast cancer to reduce their weight